Azapropazone: Its Place in the Management of Rheumatoid Conditions

Brooks, P. M. and Buchanan, W. W. (1976) Azapropazone: Its Place in the Management of Rheumatoid Conditions. Current Medical Research and Opinion, 4 94-100.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
azaproperone.pdf Full text (open access) application/pdf 470.93KB 245
Author Brooks, P. M.
Buchanan, W. W.
Title Azapropazone: Its Place in the Management of Rheumatoid Conditions
Journal name Current Medical Research and Opinion
Publication date 1976-01-01
Sub-type Article (original research)
Open Access Status File (Author Post-print)
Volume 4
Start page 94
End page 100
Language nah
Subject 321028 Rheumatology and Arthritis
320503 Clinical Pharmacology and Therapeutics
Abstract The authors review the trials carried out on azapropazone in rheumatoid arthritis and other rheumatoid conditions. They comment that in terms of efficacy azapropazone would appear to be a useful non-steroidal anti-inflammatory analgesic which compares favourably with other established antirheumatic agents against which it has been tested. Its main advantages are its low incidence of side-effects and the fact that in the majority of the trials reported azapropazone treatment was preferred by patients to that with other agents.
Keyword rheumatoid arthritis
anti-inflammatory agents
azapropazone
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown
Additional Notes This is an electronic version of an article originally published as Brooks PM, Buchanan WW. Azapropazone: Its Place in the Management of Rheumatoid Conditions. Curr Med Res Opin 1976; 4:94-100. Copied with permission of Librapharm.

Document type: Journal Article
Sub-type: Article (original research)
Collections: School of Biomedical Sciences Publications
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Thu, 24 Mar 2005, 10:00:00 EST by Di Thornthwaite on behalf of Scholarly Communication and Digitisation Service